First Cited
Last Cited

Articles citing This Document (Page 1 of 3)

Facilitating treatment initiation and reproductive care postpartum to prevent substance-exposed pregnancies: A randomized bayesian pilot trial2022
The Application of PK/PD Modeling and Simulations During Lead Optimization2006
Clinical drug evaluation using imaging readouts: regulatory perspectivesProgress in Drug Research Fortschritte Der Arzneimittelforschung Progres Des Recherches Pharmaceutiques2005
Validation des biomarqueurs, niveau de preuve et essais cliniques adaptatifs2014
Implementing Systems Toxicology in Drug Development for Regulatory Decision Making
Modeling the Progression of Disease2011
Role of the US Food and Drug Administration in Cancer Drug Development2011
Optimizing the Use of Biomarkers for Drug Development: A Clinician's Perspective
Future Challenges in Design and Ethics of Clinical Trials
Strategies for the Co-Development of Drugs and Diagnostics: FDA Perspective on Diagnostics Regulation
Absorption Models to Examine Bioavailability and Drug–Drug Interactions in Humans2010
Role of Pharmacogenomics in Drug Development2009
Pharmacogenomics in Drug Development: A Pharmaceutical Industry Perspective2008
The Role of Mass Spectrometry for Safety Evaluation in the Drug Discovery StageJournal of the Mass Spectrometry Society of Japan2008
Types of Clinical Studies2007
Regulatory Guidance and Validation of Toxicologic Biomarkers2006
Enabling Semantic Web Inferencing with Oracle Technology: Applications in Life SciencesLecture Notes in Computer Science2005
From Sequence to Genomic Medicine: Genome Policy Considerations2009
Agent-Based Modeling Approaches to Multi-Scale Systems Biology: An Example Agent-Based Model of Acute Pulmonary Inflammation2013
Can cell systems biology rescue drug discovery?Ernst Schering Research Foundation Workshop2007
Bayesian Interim Inference of Probability of Clinical Trial SuccessSpringer Proceedings in Mathematics and Statistics2013
Biomarkers: Facing the Challenges at the Crossroads of Research and Health Care
Phase 0/microdosing approaches: time for mainstream application in drug development?Nature Reviews Drug Discovery2020
Adaptive trial designs for spinal cord injury clinical trials directed to the central nervous systemSpinal Cord2020
Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric DisordersAdvances in Experimental Medicine and Biology2017
Application of Multiplex Biomarker Approaches to Accelerate Drug Discovery and DevelopmentMethods in Molecular Biology2017
[Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities]Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz2016
Adaptive design of confirmatory trials: Advances and challengesContemporary Clinical Trials2015
Catalyzing the Critical Path Initiative: FDA's progress in drug development activitiesClinical Pharmacology and Therapeutics2015
Dose Finding Studies2014
Sample Size Reestimation for Confirmatory Clinical Trials2012
Agent-based modeling and biomedical ontologies: a roadmapWiley Interdisciplinary Reviews: Computational Statistics2011
Serum cancer biomarker discovery through analysis of gene expression data sets across multiple tumor and normal tissuesJournal of Biomedical Informatics2011
Bridging the translation gap - new hopes, new challengesFundamental and Clinical Pharmacology2011
Microdialysis Versus Imaging Techniques for In Vivo Drug Distribution Measurements2011
The Application of Drug-Disease Models in the Development of Anti-Hyperglycemic AgentsAAPS Advances in the Pharmaceutical Sciences Series2011
Improving toxicity screening and drug development by using genetically defined strainsMethods in Molecular Biology2010
Overview on the Rule of FiveCurrent Protocols in Pharmacology2010
Genome Policy Considerations for Genomic Medicine2010
Economic opportunities and challenges for pharmacogenomicsAnnual Review of Pharmacology and Toxicology2010
Preclinical Drug Development Planning2010
Visualizing the landscape of selection biomarkers in current phase III oncology clinical trialsScience Translational Medicine2010
The Principles of ICH S6 and the Case-by-Case Approach2010
Likelihood inference for a two-stage design with treatment selectionBiometrical Journal2010
The future of drug discovery and development: Shifting emphasis towards personalized medicineTechnological Forecasting and Social Change2010
Impact of biomarker development on drug safety assessmentToxicology and Applied Pharmacology2010
Toxicogenomic profiling of chemically exposed humans in risk assessmentMutation Research - Reviews in Mutation Research2010
Ruthenium-based chemotherapeutics: are they ready for prime time?Cancer Chemotherapy and Pharmacology2010
Successes achieved and challenges ahead in translating biomarkers into clinical applicationsAAPS Journal2010